Literature DB >> 894512

Spironolactone: relationship between concentrations of dethioacetylated metabolite in human serum and milk.

D L Phelps, A Karim.   

Abstract

The concentration of canrenone, a principal metabolite of spironolactone, was determined in human serum and milk. The milk to serum concentration ratios of this metabolite were 0.72 at 2 hr and 0.51 at 14.5 hr after ingestation of spironolactone. It was estimated that the maximum quantity of canrenone ingested daily by a human infant via its mother's milk would be approximately 0.2% of the daily dose of spironolactone given to the mother.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 894512     DOI: 10.1002/jps.2600660841

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

Review 1.  Clinical pharmacokinetics of diuretics.

Authors:  B Beermann; M Groschinsky-Grind
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

2.  Oral Spironolactone in Post-teenage Female Patients with Acne Vulgaris: Practical Considerations for the Clinician Based on Current Data and Clinical Experience.

Authors:  Grace K Kim; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2012-03

Review 3.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 4.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 5.  Postpartum Cardiomyopathy and Considerations for Breastfeeding.

Authors:  Laura Kearney; Paul Wright; Sadeer Fhadil; Martin Thomas
Journal:  Card Fail Rev       Date:  2018-08

6.  Case Report: Induced Lactation in a Transgender Woman.

Authors:  Tamar Reisman; Zil Goldstein
Journal:  Transgend Health       Date:  2018-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.